Related Experiment Video
Updated: Jan 30, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Cereblon attenuates DNA damage-induced apoptosis by regulating the transcription-independent function of p53
1Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, Jiangsu, 215123, China.
Abstract:
Cereblon (CRBN) is the substrate receptor of the cullin 4-RING E3 ligase complex and has been employed for targeted protein degradation in the treatment of cancers. However, its normal physiological functions and molecular mechanism in the regulation of DNA damage response are largely unknown. Here we find that CRBN plays a protective role against DNA damage-induced apoptosis in cell lines and primary cells. Mechanistic studies demonstrate that although CRBN does not affect the ubiquitination and degradation of the tumor suppressor p53, it directly interacts with p53 and therefore, suppresses the interaction between p53 and anti-apoptotic regulators Bcl-2 and Bcl-XL. CRBN depletion enhances the interaction between p53 and Bcl-2/Bcl-XL, reduces mitochondrial membrane potential, increases the cleavage of caspase-3 and poly(ADP-ribose) polymerase 1, and thus promotes DNA damage-induced apoptosis in cell lines and primary cells upon etoposide treatment. Moreover, Crbn knockout mice exhibit increased mortality upon etoposide challenge. Taken together, our data elucidate a novel molecular mechanism by which CRBN inhibits DNA damage response in vitro and in vivo. This work extends our understanding of the broad spectrum of physiological roles for CRBN and may suggest its potential application in the treatment of DNA damage-associated diseases.
Insights
Cereblon (CRBN) protects cells from DNA damage-induced apoptosis by interacting with p53 and preventing its association with anti-apoptotic proteins. This discovery reveals a new role for CRBN in DNA damage response.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Cereblon (CRBN) is a key component of the CUL4-RING E3 ubiquitin ligase complex.
- CRBN is utilized for targeted protein degradation in cancer therapy.
- The physiological roles and DNA damage response mechanisms of CRBN are not well understood.
Purpose of the Study:
- To investigate the function of CRBN in the cellular response to DNA damage.
- To elucidate the molecular mechanism by which CRBN regulates DNA damage-induced apoptosis.
- To explore the in vivo relevance of CRBN's role in DNA damage response.
Main Methods:
- Cellular apoptosis assays in response to DNA damage (etoposide treatment).
- Co-immunoprecipitation to study protein-protein interactions (CRBN, p53, Bcl-2, Bcl-XL).
- Mitochondrial membrane potential assessment and caspase cleavage analysis.
- Evaluation of etoposide sensitivity in Crbn knockout mice.
Main Results:
- CRBN plays a protective role against DNA damage-induced apoptosis.
- CRBN directly interacts with p53, suppressing its interaction with Bcl-2 and Bcl-XL.
- CRBN depletion enhances p53-Bcl-2/Bcl-XL interaction, leading to increased apoptosis and reduced mitochondrial membrane potential.
- Crbn knockout mice show increased mortality upon etoposide challenge, indicating impaired DNA damage response.
Conclusions:
- CRBN inhibits DNA damage-induced apoptosis through a novel mechanism involving direct interaction with p53.
- This interaction prevents p53 from binding to anti-apoptotic proteins, thereby protecting cells from programmed cell death.
- CRBN has a significant physiological role in protecting against DNA damage, both in vitro and in vivo.
- Findings suggest potential therapeutic applications of CRBN modulation in DNA damage-associated diseases.
More Related Videos
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Master Transcription Regulators
Master Transcription Regulators
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Negative Regulator Molecules
Cooperative Binding of Transcription Regulators

